Aniracetam (Compound)

Synonyms:aniracetam, 72432-10-1, Draganon, Sarpul, 1-(4-Methoxybenzoyl)-2-pyrrolidinone, 1-(4-methoxybenzoyl)pyrrolidin-2-one, Ampamet, Ro 13-5057, 1-p-Anisoyl-2-pyrrolidinone, Ro-13-5057, 1-p-anisoylpyrrolidin-2-one, NSC-758223, 2-Pyrrolidinone, 1-(4-methoxybenzoyl)-, MLS000079240, DTXSID5045128, CHEBI:47943, 1-[(4-methoxyphenyl)carbonyl]pyrrolidin-2-one, 5L16LKN964, Ro-135057, NCGC00015116-10, SMR000038438, DTXCID3025128, Aniracetamun, Memodrin, 1-anisoyl-2-pyrrolidinone, Aniracetamun [INN-Latin], Aniracetam [USAN:INN:JAN], CAS-72432-10-1, SR-01000003147, Ro 135057, BRN 4807205, Reset, UNII-5L16LKN964, 1-(p-Methoxybenzoyl)-2-pyrrolidinon [German], Aniracetam ,(S), 1-(p-Methoxybenzoyl)-2-pyrrolidinon, MFCD00153767, Spectrum_001342, Tocris-0867, Aniracetam, >=98%, ANIRACETAM [MI], Opera_ID_294, ANIRACETAM [INN], ANIRACETAM [JAN], Spectrum3_001553, Spectrum4_000761, Spectrum5_001609, ANIRACETAM [USAN], Lopac-A-9950, Biomol-NT_000222, ANIRACETAM [MART.], ANIRACETAM [WHO-DD], Lopac0_000115, SCHEMBL70998, BSPBio_003026, KBioGR_001142, KBioSS_001822, MLS000028591, MLS001201800, Aniracetam (JAN/USAN/INN), CHEMBL36994, DivK1c_000403, SPECTRUM1503078, BPBio1_001316, GTPL4133, HMS501E05, KBio1_000403, KBio2_001822, KBio2_004390, KBio2_006958, KBio3_002526, NINDS_000403, BCPP000399, HMS2089O17, HMS2094K07, HMS2234E11, HMS3260G12, HMS3266L08, HMS3411P17, HMS3657G11, HMS3675P17, HMS3713N20, HMS3884C09, Pharmakon1600-01503078, BCP02091, Tox21_110086, Tox21_500115, 1-(4-Methoxybenzoyl)-2-pyrrolidone, HB0116, NSC758223, s1281, 1-(p-methoxybenzoyl)-2-pyrrolidinone, AKOS005066313, Tox21_110086_1, AB04115, BCP9000303, CCG-204210, CS-1793, DB04599, KS-5313, LP00115, NSC 758223, SDCCGSBI-0050103.P005, IDI1_000403, aniracetam;p-methoxybenzoyl-2-pirrolidone, NCGC00015116-01, NCGC00015116-02, NCGC00015116-03, NCGC00015116-04, NCGC00015116-05, NCGC00015116-06, NCGC00015116-07, NCGC00015116-08, NCGC00015116-09, NCGC00015116-11, NCGC00015116-12, NCGC00015116-13, NCGC00015116-24, NCGC00021402-02, NCGC00021402-05, NCGC00021402-06, NCGC00021402-07, NCGC00021402-08, NCGC00260800-01, Ro-13-3057, 1-(4-Methoxy-benzoyl)-pyrrolidin-2-one, 1-(4-Methoxybenzoyl)-2-pyrrolidinone #, AC-15651, Aniracetam p-Methoxybenzoyl-2-pirrolidone, BA164183, HY-10932, SBI-0050103.P004, EU-0100115, FT-0649064, SW199095-2, A 9950, D01883, H10883, AB00053303-14, AB00053303_15, AB00053303_16, ANIRACETAM; 1-P-ANISOYL-2-PYRROLIDINONE, A837527, Q417630, SR-01000003147-2, SR-01000003147-4, SR-01000003147-6, SR-01000003147-8, BRD-K88611939-001-02-6, BRD-K88611939-001-13-3

Pubchem:PUBCHEM:2196

Id:a2c3ca8a-66b6-5e94-ae8f-bb484f728614

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Aniracetam's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Aniracetam.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Aniracetam.

Results found

Linked to

	Label	Description
	BRD-K88611939-001-13-3 Substance (Entity type)	A Substance
	aniracetam (718e9fc8-c5a3-44cf-ba3b-d95d1a5c01e3) Collection (Entity type)	Metadatata for aniracetam
	DCSTRUCT ID 00221 Collection (Entity type)	DrugPage Collection: (DrugCentralID:00221; PubChem_CID:2196, FILE=drugcentral_drug_00221.json)
	Tadalafil in similarity relationship with Aniracetam Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Aniracetam negatively regulates SYT1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Aniracetam negatively regulates SLC7A11 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Aniracetam negatively regulates RNF167 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Aniracetam positively regulates PLAC8 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Aniracetam positively regulates SUMO3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Aniracetam negatively regulates GOLGA8A Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS